Supply Issues Becton Dickinson UK Ltd Administration set Alaris GP Volumetric Pump FKA321 (ICN 3369)
Important Customer Notice Status Update Type Supply Disruption
Ref: 2026/3369
ICN Number: 3369
- The supply issue with administration set Alaris GP volumetric pump from Becton Dickinson is continuing.
- One product remains affected and unavailable to order:
- FKA321.
- Potential indirect alternative products are available to order through our online catalogue for the affected products. However, some of these products may also become subject to intermittent supply with the increase in demand.
- See our Downloads ▼ section to access the product listing for further information on the affected product code and potential alternatives.
- We will continue to review the stock to minimise further disruption. We will update this ICN as soon as we have further information.
- The supply issue is now anticipated to be resolved by 31 July 2026.
Change:
- The supplier Becton Dickinson UK Ltd Stock Oxford has informed us of a supply issue with its administration set alaris GP volumetric pump.
- There is one product affected:
- FKA321 – Administration set Alaris GP Volumetric pump Primary set v/u 15 micron filter Roll/C 2 x SmartSite Y-ports Alaris safety clamp 0.2 micron filter R/C L/265 P/27ml 3mm id PE Taxol set.
- The supply issue is due to shipping delays.
Impact:
- FKA321 is currently suspended and unavailable to order.
- Potential indirect alternative products are available to order through our online catalogue.
- See our Downloads ▼ section to access the product listing for further information on the affected product code and potential alternatives.
- The supply issue is anticipated to be resolved by 16 July 2026.
Next Steps:
- Customers are advised to log into our website to view the potential indirect alternative products.
- We will update the ICN when we have further information.
- If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.
Please note that due to the clinical nature of these alternative products, we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.
